Lyora Therapeutics develops genetic medicines for inherited retinal diseases that currently have no treatment.
Lyora Therapeutics has raised $2.5M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2026.
Lyora Therapeutics is headquartered in Providence, United States.
Lyora Therapeutics develops genetic medicines for inherited retinal diseases that currently have no treatment.
Lyora Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lyora Therapeutics — Funding & Investors." VCBacked, July 14, 2026, https://www.vcbacked.co/company/lyora-therapeutics. Accessed September 16, 2026.
VCBacked. (2026). Lyora Therapeutics — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/lyora-therapeutics
{{cite web |title=Lyora Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lyora-therapeutics |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated